Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02990416
Title A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Angimmune LLC
Indications

melanoma

Therapies

A-dmDT390-bisFv(UCHT1) + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.